LORANGER STEVEN R 4
4 · Edwards Lifesciences Corp · Filed Nov 17, 2020
Insider Transaction Report
Form 4
LORANGER STEVEN R
Director
Transactions
- Exercise/Conversion
Director Stock Option (Right to Acquire)
2020-11-16−19,797→ 0 totalExercise: $35.20From: 2017-05-12Exp: 2023-05-11→ Common Stock (19,797 underlying) - Exercise/Conversion
Common Stock
2020-11-16$35.20/sh+19,797$696,789→ 46,965 total
Holdings
- 15,000(indirect: By Trust)
Common Stock